Literature DB >> 1489123

Capsaicin-induced cough in humans.

B Midgren1, L Hansson, J A Karlsson, B G Simonsson, C G Persson.   

Abstract

We have evaluated the properties of capsaicin as a selective cough-inducing agent in healthy human subjects. Despite frequent coughing, the subjects could inhale repeated breaths of capsaicin aerosol during 60 s without difficulty. Cough started immediately on inhalation and was most intense during the first 30 s. Cough always disappeared promptly when the capsaicin inhalation was terminated. The cough response was well reproducible and concentration-dependent up to 10 microM; at higher concentrations there was a distinct plateau of the cough response. Specific airway conductance was not changed 3 min after 50 microM capsaicin. Capsaicin (> or = 10 microM) had a burning taste, but there were no visual signs of pharyngitis or laryngitis. Citric acid (nebulized solutions 0.125 to 32%) had a choking effect and could be administered only as single breaths. There was no correlation between the cough response to citric acid and to capsaicin. Inhaled lidocaine (20 and 80 mg from nebulized solutions) caused a dose-dependent inhibition of capsaicin-induced cough. Lidocaine suppressed citric acid-induced cough as effectively as capsaicin-induced cough. In conclusion, we have characterized capsaicin-induced cough and demonstrated that it can be a useful tool in the study of cough reactivity and for evaluation of antitussive agents in humans. Capsaicin may be complementary to citric acid and may offer experimental advantages over this traditional tussive stimulus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489123     DOI: 10.1164/ajrccm/146.2.347

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

Review 1.  Cough challenge in the assessment of cough reflex.

Authors:  A H Morice; J A Kastelik; R Thompson
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

3.  Neurogenic inflammation in human airways: is it important?

Authors:  G F Joos; P R Germonpre; R A Pauwels
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

4.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 5.  Cough as an adverse effect on inhalation pharmaceutical products.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Sussan Ghassabian; John D Brannan; Heikki O Koskela; Hak-Kim Chan
Journal:  Br J Pharmacol       Date:  2020-08-07       Impact factor: 8.739

6.  Antitussive activity of iodo-resiniferatoxin in guinea pigs.

Authors:  M Trevisani; A Milan; R Gatti; A Zanasi; S Harrison; G Fontana; A H Morice; P Geppetti
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

7.  Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function.

Authors:  Peter V Dicpinigaitis; Yvonne E Gayle
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

8.  Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough.

Authors:  Nicole M Ryan; Anne E Vertigan; Sarah Bone; Peter G Gibson
Journal:  Cough       Date:  2010-07-28

9.  Effects of levodropropizine on vagal afferent C-fibres in the cat.

Authors:  H Shams; L Daffonchio; P Scheid
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

10.  Use of mannitol inhalation challenge in assessment of cough.

Authors:  Sheldon Spector
Journal:  Lung       Date:  2009-09-16       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.